<DOC>
	<DOCNO>NCT02352480</DOCNO>
	<brief_summary>The aim trial demonstrate effectiveness complete wound heal prospective , open-label , randomized trial diabetic food ulcer ( DFU ) treat use Aurix plus Usual Customary Care ( UCC ) compare group receive UCC provide 100 U.S. wound center</brief_summary>
	<brief_title>Effectiveness Aurix Therapy Diabetic Foot Ulcers</brief_title>
	<detailed_description>Aurix platelet-rich plasma gel use treatment non-healing chronic wound . Prospective observational study effectiveness Aurix demonstrate promising result regard heal DFUs , include severe Wagner grade 3 4 ulcer . The aim trial demonstrate complete wound heal prospective , open-label , randomized trial diabetic foot ulcer treat use Aurix determine time heal 12 week . Comparison make 1:1 basis Aurix + UCC versus control subject receive undefined UCC .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>1 . Medicare eligible 2 . ≥18 year age 3 . Type I II diabetes require medical treatment determine physician 4 . The large nonhealing wound , multiple wound present , single wound treat ( Index Ulcer ) Wagner 15 DFU ( see Appendix 9 Wagner Classification ) locate dorsal , plantar , medial , lateral aspect foot heel ( include toe surface ) 5 . For subject potentially multiple eligible DFUs , large ulcer select Index Ulcer study . There must least 4 cm Index Ulcer ulcer ; ulcer closer 4 cm , subject enrol ( screen failure ) 6 . Debrided ulcer size 0.5 cm2 50 cm2 7 . Subject receive UCC care ≥ 2 week treat wound clinic 8 . Demonstrated adequate offload regimen 9 . Duration ≥ 1 month first visit 10 . Subject must willing comply Protocol , assess enrol clinician . 1 . Subjects know sensitive Aurix component ( calcium chloride , thrombin , ascorbic acid ) and/or material bovine origin 2 . Presence another wound concurrently treat might interfere treatment index wind Aurix 3 . Ulcer DFU pathophysiology ( e.g. , venous , vasculitic , radiation , rheumatoid , collagen vascular disease , pressure , arterial etiology ) 4 . Patients chemotherapeutic agent malignancy wind area 5 . Subjects cognitively impair 6 . Serum albumin less 2.5 g/dL 7 . Plasma Platelet count le 100 x 109/L 8 . Hemoglobin le 10.5 g/dL 9 . Subject inadequate venous access repeat blood draw require Aurix administration .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Non Healing Wound</keyword>
</DOC>